Detalhe da pesquisa
1.
AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus-A joint EAACI-EANO position paper.
Allergy
; 2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38263898
2.
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer.
Eur Radiol
; 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388716
3.
The experience of surgical cancer patients during the COVID-19 pandemic at a large cancer centre in London.
Support Care Cancer
; 32(5): 321, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691178
4.
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry.
Lancet Oncol
; 24(4): 335-346, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898391
5.
Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden.
Br J Cancer
; 128(5): 814-824, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36522475
6.
Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes.
Br J Cancer
; 128(2): 342-353, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36402875
7.
Second Primary Malignancies in Patients with a Neuroendocrine Neoplasm in England.
Neuroendocrinology
; 113(8): 811-821, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940675
8.
Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma.
Eur Radiol
; 33(5): 3647-3659, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920518
9.
Assessing the quality of patient-reported outcome measurements for gynecological cancers: a systematic review.
Future Oncol
; 19(9): 663-678, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37128990
10.
ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer.
Support Care Cancer
; 31(5): 292, 2023 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086362
11.
The impact of 2 weeks wait referral on survival of head and neck cancer patients.
Eur Arch Otorhinolaryngol
; 280(12): 5557-5564, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37526700
12.
Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave.
Br J Cancer
; 127(7): 1289-1295, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35840733
13.
Antibodies as biomarkers for cancer risk: a systematic review.
Clin Exp Immunol
; 209(1): 46-63, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35380164
14.
Hormonal patterns in men with prediabetes and diabetes in NHANES III: possible links with prostate cancer.
Cancer Causes Control
; 33(3): 429-440, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35059918
15.
Invadopodia play a role in prostate cancer progression.
BMC Cancer
; 22(1): 386, 2022 Apr 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35397545
16.
Supportive care needs and utilization of bladder cancer patients undergoing radical cystectomy: A longitudinal study.
Psychooncology
; 31(2): 219-226, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449941
17.
The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer.
Future Oncol
; 18(10): 1211-1218, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034514
18.
Long-term effects of COVID-19 on cancer patients: the experience from Guy's Cancer Centre.
Future Oncol
; 18(32): 3585-3594, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36172860
19.
An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study.
Support Care Cancer
; 30(6): 5459-5468, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304633
20.
Safe provision of systemic anti-cancer treatment for urological cancer patients during COVID-19: a tertiary centre experience in the first wave of COVID-19.
BMC Urol
; 22(1): 71, 2022 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488333